35Pharma is dedicated to designing and developing best-in-class ligand traps that target Activin x GDF biology to address diseases with high unmet medical need including pulmonary hypertension, heart failure, and obesity
35Pharma is dedicated to designing and developing best-in-class ligand traps that target Activin x GDF biology to address diseases with high unmet medical need including pulmonary hypertension, heart failure, and obesity.